Results 41 to 50 of about 1,602 (225)

Glomus jugulare tumor presenting as mastoiditis in a patient with familial paraganglioma syndrome: A case report and review of the literature

open access: yesInterdisciplinary Neurosurgery, 2020
Glomus jugulare paragangliomas (PGLs) are rare, slow-growing, hypervascular lesions that represent a type of extra-adrenal PGL, originating within the wall of jugular bulb. We report the first case of a 59-year-old woman with hereditary PGL syndrome, who
Georgios Alexopoulos   +4 more
doaj   +1 more source

Computational Intelligence and Metaheuristic Techniques for Brain Tumor Detection through IoMT‐Enabled MRI Devices

open access: yesWireless Communications and Mobile Computing, Volume 2022, Issue 1, 2022., 2022
The brain tumor is the 22nd most common cancer worldwide, with 1.8% of new cancers. It is likely the most severe ailment that necessitates early discovery and treatment, and it requires the competence of neurosubject‐matter experts and radiologists.
Damandeep Kaur   +7 more
wiley   +1 more source

Image‐guided robotic radiosurgery for glomus jugulare tumors—Multicenter experience and review of the literature

open access: yesHead &Neck, Volume 43, Issue 1, Page 35-47, January 2021., 2021
Abstract Background Glomus jugulare tumors (GJTs) are challenging to treat due to their vascularization and location. This analysis evaluates the effectiveness and safety of image‐guided robotic radiosurgery (RRS) for GJTs in a multicenter study and reviews the existing radiosurgical literature.
Felix Ehret   +13 more
wiley   +1 more source

Gamma knife radiosurgery for glomus jugulare tumors: Therapeutic advantages of minimalism in the skull base [PDF]

open access: green, 2008
Context: Glomus jugulare (GJ) tumors are paragangliomas found in the region of the jugular foramen. Surgery with/without embolization and conventional radiotherapy has been the traditional management option.
Anupama Gupta   +5 more
core   +4 more sources

Perioperative Management of Catecholamine-Secreting Glomus Jugulare Tumors

open access: yesJournal of Neurological Surgery Reports, 2014
To treat patients with a catecholamine-secreting glomus jugulare tumor, perioperative management is important. Perioperative catecholamine hypersecretion causes severe problems in the treatment of a catecholamine-secreting glomus tumor.
Yu Teranishi   +4 more
doaj   +1 more source

A legacy of tinnitus: multiple head and neck paragangliomas

open access: yesRare Tumors, 2009
We describe the case of a patient who presented with a right-sided glomus jugulare tumor and bilateral glomus vagale tumors. These proved to be nonmalignant paragangliomas on histopathological analysis.
Jeremy J. Turner   +6 more
doaj   +1 more source

Analysis of the Effect of Facial Nerve Processing in the Surgery of Paraganglioma of the Lateral Skull Base Area

open access: yesXiehe Yixue Zazhi, 2021
Objective  To summarize the key points of the operation related to the facial nerve function after surgery of paraganglioma involving the jugular foramen in the lateral skull base.
ZHANG Liqin   +4 more
doaj   +1 more source

Jugular paraganglioma treatment at the UMC Maribor

open access: yesZdravniški Vestnik, 2017
Background: Jugular paragangliomas are rare, almost exclusively benign and slowly growing tumors. Arising from the cells of paraganglia in jugular bulb, they infiltrate the temporal bone and later grow intracranially.
Janez Rebol   +4 more
doaj   +1 more source

Relationship between the Enhanced MRI Features of Preoperative Brain Volume Imaging and Surgical Methods of the Glomus Jugulare Tumor

open access: yesXiehe Yixue Zazhi, 2021
Objective  To investigate the relationship between the enhanced MRI features of preopera-tive brain volume imaging (BRAVO) and surgical methods in patients with glomus jugulare tumor (GJT).
CHEN Yu   +10 more
doaj   +1 more source

Radiosurgery for Glomus Jugulare Tumors

open access: yesTechnology in Cancer Research & Treatment, 2007
Results for treating glomus jugulare tumors with radiosurgery have been limited by short follow-up and small number of patients. We report our experience using LINAC or CyberKnife in 21 tumors with a median follow-up of 66 months (Mean follow-up of 60 months). In addition, we have a subset of eight patients that were followed out for more than 10 years.
Michael, Lim   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy